ZYUS Life Sciences Corporation (CVE:ZYU – Free Report) – Analysts at Stifel Canada issued their FY2025 earnings per share (EPS) estimates for shares of ZYUS Life Sciences in a research note issued to investors on Thursday, September 19th. Stifel Canada analyst J. Keywood expects that the company will post earnings per share of ($0.38) for the year.
ZYUS Life Sciences (CVE:ZYU – Get Free Report) last issued its quarterly earnings results on Wednesday, August 28th. The company reported C($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of C($0.08) by C$0.01. The business had revenue of C$0.12 million for the quarter, compared to analyst estimates of C$0.11 million.
ZYUS Life Sciences Price Performance
Read More
- Five stocks we like better than ZYUS Life Sciences
- How to Calculate Return on Investment (ROI)
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Technology Stocks Explained: Here’s What to Know About Tech
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Canada Bond Market Holiday: How to Invest and Trade
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for ZYUS Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZYUS Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
